PortfoliosLab logo
IOVA vs. MATW
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between IOVA and MATW is 0.52, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.0
Correlation: 0.5

Performance

IOVA vs. MATW - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Iovance Biotherapeutics, Inc. (IOVA) and Matthews International Corporation (MATW). The values are adjusted to include any dividend payments, if applicable.

-100.00%-80.00%-60.00%-40.00%-20.00%0.00%20.00%December2025FebruaryMarchAprilMay
-96.97%
-26.24%
IOVA
MATW

Key characteristics

Sharpe Ratio

IOVA:

-0.97

MATW:

-0.54

Sortino Ratio

IOVA:

-1.84

MATW:

-0.63

Omega Ratio

IOVA:

0.79

MATW:

0.93

Calmar Ratio

IOVA:

-0.74

MATW:

-0.37

Martin Ratio

IOVA:

-1.52

MATW:

-1.38

Ulcer Index

IOVA:

47.46%

MATW:

18.42%

Daily Std Dev

IOVA:

74.54%

MATW:

47.51%

Max Drawdown

IOVA:

-99.37%

MATW:

-75.27%

Current Drawdown

IOVA:

-97.91%

MATW:

-68.52%

Fundamentals

Market Cap

IOVA:

$1.19B

MATW:

$633.31M

EPS

IOVA:

-$1.28

MATW:

-$1.97

PEG Ratio

IOVA:

0.00

MATW:

1.92

PS Ratio

IOVA:

7.25

MATW:

0.36

PB Ratio

IOVA:

1.67

MATW:

1.61

Total Revenue (TTM)

IOVA:

$163.35M

MATW:

$1.28B

Gross Profit (TTM)

IOVA:

$41.24M

MATW:

$374.86M

EBITDA (TTM)

IOVA:

-$255.01M

MATW:

$33.00M

Returns By Period

In the year-to-date period, IOVA achieves a -55.00% return, which is significantly lower than MATW's -27.72% return. Over the past 10 years, IOVA has underperformed MATW with an annualized return of -12.16%, while MATW has yielded a comparatively higher -6.53% annualized return.


IOVA

YTD

-55.00%

1M

2.46%

6M

-68.10%

1Y

-73.36%

5Y*

-36.49%

10Y*

-12.16%

MATW

YTD

-27.72%

1M

-9.46%

6M

-13.37%

1Y

-23.10%

5Y*

-0.33%

10Y*

-6.53%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

IOVA vs. MATW — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IOVA
The Risk-Adjusted Performance Rank of IOVA is 66
Overall Rank
The Sharpe Ratio Rank of IOVA is 55
Sharpe Ratio Rank
The Sortino Ratio Rank of IOVA is 33
Sortino Ratio Rank
The Omega Ratio Rank of IOVA is 55
Omega Ratio Rank
The Calmar Ratio Rank of IOVA is 88
Calmar Ratio Rank
The Martin Ratio Rank of IOVA is 77
Martin Ratio Rank

MATW
The Risk-Adjusted Performance Rank of MATW is 2121
Overall Rank
The Sharpe Ratio Rank of MATW is 2222
Sharpe Ratio Rank
The Sortino Ratio Rank of MATW is 2121
Sortino Ratio Rank
The Omega Ratio Rank of MATW is 2222
Omega Ratio Rank
The Calmar Ratio Rank of MATW is 2929
Calmar Ratio Rank
The Martin Ratio Rank of MATW is 1212
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

IOVA vs. MATW - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Iovance Biotherapeutics, Inc. (IOVA) and Matthews International Corporation (MATW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for IOVA, currently valued at -0.97, compared to the broader market-2.00-1.000.001.002.003.00
IOVA: -0.97
MATW: -0.54
The chart of Sortino ratio for IOVA, currently valued at -1.84, compared to the broader market-6.00-4.00-2.000.002.004.00
IOVA: -1.84
MATW: -0.63
The chart of Omega ratio for IOVA, currently valued at 0.79, compared to the broader market0.501.001.502.00
IOVA: 0.79
MATW: 0.93
The chart of Calmar ratio for IOVA, currently valued at -0.74, compared to the broader market0.001.002.003.004.005.00
IOVA: -0.74
MATW: -0.37
The chart of Martin ratio for IOVA, currently valued at -1.52, compared to the broader market-10.000.0010.0020.00
IOVA: -1.52
MATW: -1.38

The current IOVA Sharpe Ratio is -0.97, which is lower than the MATW Sharpe Ratio of -0.54. The chart below compares the historical Sharpe Ratios of IOVA and MATW, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.00December2025FebruaryMarchAprilMay
-0.97
-0.54
IOVA
MATW

Dividends

IOVA vs. MATW - Dividend Comparison

IOVA has not paid dividends to shareholders, while MATW's dividend yield for the trailing twelve months is around 4.94%.


TTM20242023202220212020201920182017201620152014
IOVA
Iovance Biotherapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
MATW
Matthews International Corporation
4.94%3.50%2.54%2.92%2.36%2.87%2.12%1.90%1.33%0.81%1.01%0.95%

Drawdowns

IOVA vs. MATW - Drawdown Comparison

The maximum IOVA drawdown since its inception was -99.37%, which is greater than MATW's maximum drawdown of -75.27%. Use the drawdown chart below to compare losses from any high point for IOVA and MATW. For additional features, visit the drawdowns tool.


-100.00%-90.00%-80.00%-70.00%-60.00%-50.00%December2025FebruaryMarchAprilMay
-97.91%
-68.52%
IOVA
MATW

Volatility

IOVA vs. MATW - Volatility Comparison

Iovance Biotherapeutics, Inc. (IOVA) has a higher volatility of 27.79% compared to Matthews International Corporation (MATW) at 16.64%. This indicates that IOVA's price experiences larger fluctuations and is considered to be riskier than MATW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%30.00%December2025FebruaryMarchAprilMay
27.79%
16.64%
IOVA
MATW

Financials

IOVA vs. MATW - Financials Comparison

This section allows you to compare key financial metrics between Iovance Biotherapeutics, Inc. and Matthews International Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00100.00M200.00M300.00M400.00M500.00MAprilJulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober
73.69M
401.84M
(IOVA) Total Revenue
(MATW) Total Revenue
Values in USD except per share items